COVID-19 진단 시장 : 기술별, 제품별, 채널별, 국가별 시장 예측 - 경영진 및 컨설턴트용 가이드 포함(2026-2030년)

Report Overview:

The pandemic may be over but Covid-19 is here to stay. Multiple competitors are vying for the very lucrative future for respiratory diagnostics.

A new dynamic market is emerging for Covid - 19 based diagnostics. Testing is moving into physicians' offices and even into the home. Saliva tests? Handheld multiplex testers? Home based testing sticks? And what about the Workplace market where safety is paramount? And what happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in our latest report.

Revenue, technology, products and channels. They are all looked at in this complete report that provides detailed breakdowns by country and regions. Get on top of the situation quickly with our Market Guides and Situation Analysis.

All report data is available in Excel format on request. Make projections with confidence using the latest data.

Table of Contents

1 Market Guides

• 1.1 Strategic Situation Analysis
• 1.2 Guidance for Executives
• 1.3 Guidance for Management Consultants and Investment Advisors

2 Introduction and Market Definition

• 2.1 What are Pandemics?
• 2.2 The Role of Zoonosis
• 2.3 Market Definition
  • 2.3.1 PCR
  • 2.3.2 PCR Multiplex
  • 2.3.3 SEQ
  • 2.3.4 Antigen
  • 2.3.5 Antibodies
  • 2.3.6 Instruments
  • 2.3.7 Reagents and Kits
  • 2.3.8 Extract
  • 2.3.9 Collect
  • 2.3.10 Public
  • 2.3.11 Hospital
  • 2.3.12 Clinic
  • 2.3.13 Workplace
  • 2.3.14 DTC/OTC
  • 2.3.15 Wastewater
• 2.4 Methodology
  • 2.4.1 Sources
  • 2.4.2 Authors
• 2.5 Historical Perspective on Pandemics
  • 2.5.1 HIV/AIDS PANDEMIC 2005-2012
  • 2.5.2 FLU PANDEMIC 1968
  • 2.5.3 ASIAN FLU 1956-1958
  • 2.5.4 SPANISH FLU 1918
  • 2.5.5 SIXTH CHOLERA PANDEMIC 1910-1911
  • 2.5.6 FLU PANDEMIC 1889-1890
  • 2.5.7 THE BLACK DEATH 1346-1353

3 The Pandemic Overview

• 3.1 What is a Virus?
  • 3.1.1 Is a Virus Alive?
  • 3.1.2 Viral Structure
  • 3.1.3 The Viral Genome
  • 3.1.4 Viral Mutation
• 3.2 The Coronavirus
  • 3.2.1 Severe acute respiratory syndrome (SARS)
  • 3.2.2 Middle East respiratory syndrome (MERS)
  • 3.2.3 COVID-19. The SARS CoV 2 Virus.
    • 3.2.3.1 Signs and symptoms
    • 3.2.3.2 Transmission
    • 3.2.3.3 Diagnosis
    • 3.2.3.4 Prevention
    • 3.2.3.5 Management
    • 3.2.3.6 Prognosis
    • 3.2.3.7 A Note on Global Statistics Reporting
• 3.3 Pandemic Diagnostics
  • 3.3.1 Risk Management - Spark and Spread
  • 3.3.2 Dx Technology - Nucleic Acid Based
  • 3.3.3 Dx Technology - Immunoassay
  • 3.3.4 Time to Market and Preparedness Issues

4 Industry Structure

• 4.1 Players in a Dynamic Market
  • 4.1.1 Academic Research Lab
  • 4.1.2 Diagnostic Test Developer
  • 4.1.3 Instrumentation Supplier
  • 4.1.4 Chemical/Reagent Supplier
  • 4.1.5 Pathology Supplier
  • 4.1.6 Independent Clinical Laboratory
  • 4.1.7 Public National/regional Laboratory
  • 4.1.8 Hospital Laboratory
  • 4.1.9 Physicians Office Lab (POLS)
  • 4.1.10 Audit Body
  • 4.1.11 Certification Body

5 Diagnostic Company Profiles

• 5.1 Advanced Biological Laboratories
• 5.2 Abbott Laboratories
• 5.3 Accel Diagnostics
• 5.4 Accelerate Diagnostics
• 5.5 Access Bio
• 5.6 ADT Biotech
• 5.7 Agilent
• 5.8 Altona Diagnostics
• 5.9 Alveo Technologies
• 5.10 Anatolia Geneworks
• 5.11 Anitoa
• 5.12 Applied BioCode
• 5.13 Applied DNA Sciences
• 5.14 Aureum Diagnostics
• 5.15 Aurora Biomed
• 5.16 Aus Diagnostics
• 5.17 Autobio Diagnostics
• 5.18 Autonomous Medical Devices
• 5.19 Beckman Coulter Diagnostics (Danaher)
• 5.20 Becton, Dickinson and Company
• 5.21 BGI Genomics Co. Ltd
• 5.22 BillionToOne
• 5.23 Binx Health
• 5.24 Biocartis
• 5.25 Biodesix Inc.
• 5.26 BioFire Diagnostics (bioMerieux)
• 5.27 BioGX
• 5.28 Biolidics Ltd
• 5.29 bioMerieux Diagnostics
• 5.30 Bioneer Corporation
• 5.31 Bio-Rad Laboratories, Inc
• 5.32 Bio-Reference Laboratories
• 5.33 Boditech Med, Inc
• 5.34 Bosch Healthcare Solutions GmbH
• 5.35 Celemics
• 5.36 Cepheid (Danaher)
• 5.37 Cerstest Biotec
• 5.38 Chembio
• 5.39 Co Diagnostics
• 5.40 Color Genomics
• 5.41 CTK Biotech
• 5.42 Cube Dx
• 5.43 Cue Health
• 5.44 Curetis (OpGen)
• 5.45 Detect
• 5.46 Diagenode Diagnostics (Hologic)
• 5.47 Diasorin S.p.A.
• 5.48 Domus Diagnostics
• 5.49 Ellume
• 5.50 Enzo Biochem
• 5.51 Everywell
• 5.52 Fluxergy
• 5.53 Fujirebio
• 5.54 Fulgent Genetics
• 5.55 Fusion Genomics.
• 5.56 Fyr Diagnostics
• 5.57 Genedrive
• 5.58 Genetic Signatures
• 5.59 GenMark Dx (Roche)
• 5.60 Genomadix
• 5.61 Gold Standard Diagnostics
• 5.62 Hologic
• 5.63 Illumina
• 5.64 Immunexpress
• 5.65 Inflammatix
• 5.66 Innova Medical Group
• 5.67 J&J Innovative Medicine
• 5.68 Karius
• 5.69 Laboratory Corporation of America
• 5.70 Letsgetchecked
• 5.71 LightDeck Diagnostics
• 5.72 LumiraDx
• 5.73 Mammoth Biosciences
• 5.74 Mayo Clinic Laboratories
• 5.75 Meep
• 5.76 Meridian Bioscience
• 5.77 Mesa Laboratories, Inc.
• 5.78 Molbio Diagnostics
• 5.79 NanoDx
• 5.80 Nanomix
• 5.81 Novacyt
• 5.82 Nuclein
• 5.83 OnsiteGene
• 5.84 OraSure Technologies
• 5.85 Oxford Nanopore Technologies
• 5.86 Prenetics
• 5.87 Primerdesign (Novacyt)
• 5.88 Prominex
• 5.89 Proof Diagnostics
• 5.90 Qiagen
• 5.91 QuantuMDx
• 5.92 Quest Diagnostics
• 5.93 QuidelOrtho
• 5.94 Randox Toxicology
• 5.95 R-Biopharm AG
• 5.96 Revvity
• 5.97 Roche Diagnostics
• 5.98 Salignostics
• 5.99 Scope Fluidics
• 5.100 SD Biosensor
• 5.101 Seegene
• 5.102 Sekisui Diagnostics
• 5.103 Sherlock Biosciences
• 5.104 Siemens Healthineers
• 5.105 Singular Genomics
• 5.106 Sona Nanotech
• 5.107 SpeeDx
• 5.108 Standard BioTools
• 5.109 Streamline Scientific
• 5.110 Talis Biomedical
• 5.111 Thermo Fisher Scientific
• 5.112 Ultima Genomics
• 5.113 Uniogen
• 5.114 Vela Diagnostics
• 5.115 Veredus Laboratories
• 5.116 Vircell
• 5.117 Visby Medical
• 5.118 Wantai Biopharm
• 5.119 YD Diagnostics
• 5.120 Zhejiang Orient Gene Biotech

6 Covid-19 Diagnostics Recent Developments

• 6.1 Recent Developments - Importance and How to Use This Section
  • 6.1.1 Importance of These Developments
  • 6.1.2 How to Use This Section
• 6.2 SEKISUI DX to Provide C19/Flu Test to the POC and Home Markets
• 6.3 Co-Diagnostics Submit Enhanced C19 Test
• 6.4 AI Blood Test Detects Long COVID with 93% Accuracy
• 6.5 Roche Diagnostics Growth Offset by COVID Sales Declines
• 6.6 Credo Preps MDx System, Multiplex Respiratory Test for US Launch
• 6.7 Acon Laboratories Gets FDA EAU for OTC COVID, Flu Test
• 6.8 Impact of Long COVID Revealed
• 6.9 QuidelOrtho Receives Clearance for Home COVID-19 Test
• 6.10 SEKISUI Dx Receives EAU for the OSOMR Flu SARS-CoV-2 Combo Test
• 6.11 Johns Hopkins Shows COVID-19 Tests Done at Home Are Reliable
• 6.12 Walgreens Offers COVID-19 and Flu Testing
• 6.13 Home Test to Treat program extends nationwide
• 6.14 New test for long COVID Possible
• 6.15 Labcorp Gets Approval for Sequencing-Based COVID Test
• 6.16 Post-Pandemic, Patients Savvy About ID Diagnostics
• 6.17 Discover Labs Obtains EUA for RT-PCR COVID Test
• 6.18 Sensible Dx to Launch 10-Minute POC PCR System
• 6.19 Aptitude Medical Systems Aiming for At-Home Market
• 6.20 Qorvo To Emerge as More Than a COVID Company
• 6.21 End of COVID-19 Emergency Lowers Diagnostics Revenue
• 6.22 FDA Issues EUA for GenBody At-Home COVID Test
• 6.23 CTK Biotech Gets EAU for At-Home COVID Antigen Test
• 6.24 FDA Grants EAU for Premier Medical At-Home COVID Assay
• 6.25 QuidelOrtho Seeks Home Testing Contract
• 6.26 Aptitude Medical Gets EUA for Over-the-Counter COVID Saliva MDx
• 6.27 Siemens Healthineers Gains CE Marks for Seasonal Viral Assays
• 6.28 NanoDx Prepares for POC Platform Commercialization With TBI, COVID Tests
• 6.29 North American Dx Recalls Covid Rapid Antigen Tests
• 6.30 Domus Dx to Launch OC Diagnostics Test System
• 6.31 Becton Dickinson, ReturnSafe Collaborate on COVID-19 Testing
• 6.32 Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
• 6.33 At-Home COVID Test Coverage
• 6.34 LuminUltra Wins 500-Site CDC Wastewater Testing Contract
• 6.35 Sense Biodetection to Debut Instrument-Free Point-of-Care MDx
• 6.36 Tests Called Back

7 The Global Market for COVID-19 Diagnostics

• 7.1 Global Market Overview by Country
  • 7.1.1 Table - Global Market by Country
  • 7.1.2 Chart - Global Market by Country
• 7.2 Global Market by Technology - Overview
  • 7.2.1 Table - Global Market by Technology
  • 7.2.2 Chart - Global Market by Technology - Base/Final Year Comparison
  • 7.2.3 Chart - Global Market by Technology - Base Year
  • 7.2.4 Chart - Global Market by Technology - End Year
  • 7.2.5 Chart - Global Market by Technology - Share by Year
  • 7.2.6 Chart - Global Market by Technology - Segments Growth
• 7.3 Global Market by Product - Overview
  • 7.3.1 Table - Global Market by Product
  • 7.3.2 Chart - Global Market by Product - Base/Final Year Comparison
  • 7.3.3 Chart - Global Market by Product - Base Year
  • 7.3.4 Chart - Global Market by Product - End Year
  • 7.3.5 Chart - Global Market by Product - Share by Year
  • 7.3.6 Chart - Global Market by Product - Segments Growth
• 7.4 Global Market by Channel - Overview
  • 7.4.1 Table - Global Market by Channel
  • 7.4.2 Chart - Global Market by Channel - Base/Final Year Comparison
  • 7.4.3 Chart - Global Market by Channel - Base Year
  • 7.4.4 Chart - Global Market by Channel - End Year
  • 7.4.5 Chart - Global Market by Channel - Share by Year
  • 7.4.6 Chart - Global Market by Channel - Segments Growth

8 Global COVID-19 Diagnostic Markets - By Technology

• 8.1 PCR
  • 8.1.1 Table PCR - by Country
  • 8.1.2 Chart - PCR Growth
• 8.2 PCR Multiplex
  • 8.2.1 Table PCR Multiplex - by Country
  • 8.2.2 Chart - PCR Multiplex Growth
• 8.3 Sequencing
  • 8.3.1 Table Sequencing - by Country
  • 8.3.2 Chart - Sequencing Growth
• 8.4 Antibody
  • 8.4.1 Table Antibody - by Country
  • 8.4.2 Chart - Antibody Growth
• 8.5 Antigen
  • 8.5.1 Table Antigen - by Country
  • 8.5.2 Chart - Antigen Growth

9 Global COVID-19 Diagnostic Markets - By Product

• 9.1 Instruments
  • 9.1.1 Table Instruments - by Country
  • 9.1.2 Chart - Instruments Growth
• 9.2 Reagents & Kits
  • 9.2.1 Table Reagents & Kits - by Country
  • 9.2.2 Chart - Reagents & Kits Growth
• 9.3 Extraction
  • 9.3.1 Table Extraction - by Country
  • 9.3.2 Chart - Extraction Growth
• 9.4 Collection
  • 9.4.1 Table Collection - by Country
  • 9.4.2 Chart - Collection Growth

10 Global COVID-19 Diagnostic Markets - By Channel

• 10.1 Public
  • 10.1.1 Table Public - by Country
  • 10.1.2 Chart - Public Growth
• 10.2 Hospital
  • 10.2.1 Table Hospital - by Country
  • 10.2.2 Chart - Hospital Growth
• 10.3 Clinic
  • 10.3.1 Table Clinic - by Country
  • 10.3.2 Chart - Clinic Growth
• 10.4 Workplace
  • 10.4.1 Table Workplace - by Country
  • 10.4.2 Chart - Workplace Growth
• 10.5 DTC/OTC
  • 10.5.1 Table DTC/OTC - by Country
  • 10.5.2 Chart - DTC/OTC Growth
• 10.6 Wastewater
  • 10.6.1 Table Wastewater - by Country
  • 10.6.2 Chart - Wastewater Growth

11 Appendix

• 11.1 U.S., Europe, Asia Approved COVID-19 Assays

Table of Tables

• Table 1 Who List of Potential Pandemic Pathogens
• Table 2 Characteristics of Coronavirus Pandemic Infections
• Table 3 COVID-19 Symptoms
• Table 4 Market Players by Type
• Table 5 Global Market by Region
• Table 6 Global Market by Technology
• Table 7 Global Market by Product
• Table 8 Global Market by Channel
• Table 9 PCR by Country
• Table 10 PCR Multiplex by Country
• Table 11 Sequencing by Country
• Table 12 Antibody by Country
• Table 13 Antigen by Country
• Table 14 Instruments by Country
• Table 15 Reagents & Kits by Country
• Table 16 Extraction by Country
• Table 17 Collection by Country
• Table 18 Public by Country
• Table 19 Hospital by Country
• Table 20 Clinic by Country
• Table 21 Workplace by Country
• Table 22 DTC/OTC by Country
• Table 23 Wastewater by Country
• Table 24 Approved Covid-19 Assays

Table of Figures

• Figure 1 Global Distribution Pandemic Preparedness
• Figure 2 Global Pandemic Pathogen Status
• Figure 3 Estimated Economic Impact of Viral Pandemic by Region
• Figure 4 Historical Pandemics Infographic
• Figure 5 Antigenic Drift Creates a new Strain of Virus
• Figure 6 Structure of Coronaviruses
• Figure 7 The Road to Diagnostics
• Figure 8 Global Market Share Chart
• Figure 9 Base/Final Year Comparison Chart
• Figure 10 Global Markets by Technology Base Year
• Figure 11 Global Markets by Technology End Year
• Figure 12 Global Markets by Technology Share by Year
• Figure 13 Global Markets by Technology Segment Growth
• Figure 14 Global Market by Product Base vs. Final
• Figure 15 Global Market by Product Base Year
• Figure 16 Global Market by Product End Year
• Figure 17 Global Market by Product Share by Year
• Figure 18 Global Market by Product Segments Growth
• Figure 19 Global Market by Channel - Base vs. Final
• Figure 20 Global Market by Channel - Base Year
• Figure 21 Global Market by Channel - End Year
• Figure 22 Global Market by Channel - Share by Year
• Figure 23 Global Market by Channel - Segments Growth
• Figure 24 PCR Growth
• Figure 25 PCR Multiplex Growth
• Figure 26 Sequencing Growth
• Figure 27 Antibody Growth
• Figure 28 Antigen Growth
• Figure 29 Instruments Growth
• Figure 30 Reagents & Kits Growth
• Figure 31 Extraction Growth
• Figure 32 Collection Growth
• Figure 33 Public Growth
• Figure 34 Hospital Growth
• Figure 35 Clinic Growth
• Figure 36 Workplace Growth
• Figure 37 DTC/OTC Growth
• Figure 38 Wastewater Growth